STAT

NOVEMBER 4, 2024

One ad shows two older men talking jovially on a front porch, “Vietnam veteran” visible on one of their hats. Another shows an older man in military regalia, arms crossed, smiling proudly at the camera.  Under names like “Patriot Plan,” “Courage MA,” and “Honor” plan, all of the major private Medicare insurers are courting veterans directly, selling plans that their ads say complement their Veterans Affairs coverage with benefits like

309

309

Pharmacy Is Right For Me

NOVEMBER 4, 2024

Meet Lila, a passionate fourth-year Pharm.D. student at Auburn University Harrison College of Pharmacy. During her APPE rotation with the American Association of Colleges of Pharmacy , Lila opened up about her inspiring journey to find the perfect pharmacy school and how, with the guidance of mentors, she discovered her true “Pharmily.” How did you choose your pharmacy school/college or graduate program?

130

130

STAT

NOVEMBER 4, 2024

Researchers like to say that science is self-correcting, that knowledge is slowly but surely refined by new findings that build on or debunk old ones. But this process is far from perfect and is hampered by sloppy experiments or, in some cases, faked results. A small, tight-knit community of scientific sleuths has been unearthing growing evidence that many studies, including landmark papers published in top journals, contain manipulated images and falsified findings.

294

294

PharmaVoice

NOVEMBER 4, 2024

Pfizer’s second-to-market goals for its oral GLP-1 drugs underscore big opportunities in the space.

147

147

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

STAT

NOVEMBER 4, 2024

The word “Tuskegee” has long embodied the painful symbol of medical racism, epitomizing how ethnically uninformed research practices have harmed Black Americans. It is impossible to erase this painful history. But we — one of us working for Tuskegee University, the other for Southern Research — are working on an innovative project to create a future in which Black Americans participate more fully in clinical research and share in its benefits.

299

299

PharmaVoice

NOVEMBER 4, 2024

Integrating patient access programs with the systems healthcare providers use daily increases speed to therapy.

130

130

pharmaphorum

NOVEMBER 4, 2024

US district court grants an injunction sought by Incyte on the launch of Sun Pharma's recently approved Leqselvi for alopecia areata

97

97

STAT

NOVEMBER 4, 2024

The U.K. pharmaceutical company AstraZeneca has become the largest multinational drugmaker in China, drawing 13% of its $5.8 billion in revenue last year from there, against a backdrop of an acute economic slowdown in the country and a major anti-corruption campaign aimed at the health care industry. Now, the question is whether AstraZeneca became overly aggressive in its ambitions.

Pharmaceutical Companies 245

Pharmaceutical Companies Pharmaceutical Companies Drug Development 245

The Pharmacist

NOVEMBER 4, 2024

Any dispensations to provide financial relief for health bodies impacted by rising National Insurance contributions should include community pharmacy, Community Pharmacy England (CPE) has stressed. In a statement shared on Friday (1 November), Janet Morrison, CPE chief executive, said the negotiator was 'deeply concerned about the impact of the Autumn Budget on a pharmacy sector already […] The post Any National Insurance exemptions should include community pharmacy, says CPE appeared firs

Community Pharmacies 84

Community Pharmacies 84

STAT

NOVEMBER 4, 2024

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so predictable routine of online meetings, phone calls, and deadlines has returned. But you knew this would happen, yes? The world, such as it is, continues to spin. So to cope, we are brewing a cup of stimulation in the Pharmalot cafeteria.

Compounding 226

Compounding Pharmaceutical Companies Pharmaceutical Companies 226

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

Pharmaceutical Technology

NOVEMBER 4, 2024

Researchers from Northwestern and Case Western Reserve universities have developed a polymer therapeutic to treat Huntington's disease.

83

83

STAT

NOVEMBER 4, 2024

Medicare regulators on Friday finalized rules to pay for some mental health apps, a breakthrough for digital therapeutics companies that have struggled for a foothold in the health care system. The new rule creates codes that allow clinicians to bill Medicare for providing the apps and related services to their patients. Beginning January 1, 2025, the codes will enable payment for mental health apps authorized by the Food and Drug Administration under a specific regulation that includes just a h

222

222

pharmaphorum

NOVEMBER 4, 2024

NHS England starts pilot trial of an iPhone app and device that could be used by nurses to speed up reviews of suspected throat cancer cases.

82

82

STAT

NOVEMBER 4, 2024

This story first appeared in The Readout newsletter.  Sign up for The Readout  and receive STAT’s award-winning biotech news delivered straight to your inbox.  Morning! Today, we see even further potential for GLP-1 drugs, this time in MASH. We look at China’s probe into AstraZeneca, and have a cool video on patent thickets.

Drug Pricing 210

Drug Pricing Drug Development 210

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

The Pharmacist

NOVEMBER 4, 2024

Two in 10 patients think only GPs can treat minor ailments, a poll commissioned by the National Pharmacy Association (NPA) has suggested. And more than a third (36%) were unaware of the Pharmacy First service, the online polling of 2,052 UK adults found. The survey, carried out by Research without Barriers between 21 October and […] The post Poll reveals patient myths about antibiotics and minor ailments appeared first on The Pharmacist.

Vaccines 70

Vaccines 70

STAT

NOVEMBER 4, 2024

Recently, the smoldering embers of conflict in my family’s rare disease community have burst into flames over the use of an eponym: Niemann-Pick. An eponym is a name derived from a person who first discovered a disease or who was otherwise closely associated with its identity. Such was the case for a neurodegenerative condition observed in a child and documented by Alfred Niemann in 1914.

Documentation 194

Documentation 194

BioPharma Dive

NOVEMBER 4, 2024

Wall Street analysts were impressed by data showing competitive rates of weight loss for Viking’s therapy, but shares in the company still slipped.

73

73

STAT

NOVEMBER 4, 2024

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.  Sign up here. Need a distraction from your election anxiety? May I suggest the new album from Québécois fiddle whizzes Alexis Chartrand and Nicolas Babineau, which dropped on Friday and has us trad heads abuzz?

159

159

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

FDA Law Blog: Biosimilars

NOVEMBER 4, 2024

By Sara W. Koblitz & Charles D. Snow & Karla L. Palmer & John W.M. Claud — As we reported back in January, Phibro Animal Health Corporation challenged FDA’s decision to remove a drug called carbadox—used as an antimicrobial drug to treat gastrointestinal disease in food-producing pigs—from the market. More specifically, FDA rescinded approval of a “regulatory method” that Phibro used to establish that carbadox is safe and effective.

64

64

pharmaphorum

NOVEMBER 4, 2024

Accord Healthcare unveils £50m investment, backed by the UK government, that will see a new manufacturing facility built in Newcastle

71

71

Express Pharma

NOVEMBER 4, 2024

Telehealth firm Hims & Hers Health said on Monday it plans to bring a generic version of Novo Nordisk’s diabetes drug, liraglutide, to its platform in 2025. “We have already confirmed a core supplier for this addition and over the next few months expect to finish completing test and batch validation, as well as confirming certificates of analysis,” the company said.

Compounding 59

Compounding Diabetes 59

The Pharmacist

NOVEMBER 4, 2024

Increases to Employers’ National Insurance Contributions (NIC) and National Living Wage (NLW) outlined in the Autumn Budget could cost an average community pharmacy premises more than £12,000 each year - totalling around £125m across the sector as a whole. The estimate is based on analysis by the Independent Pharmacies Association (IPA), which calculated the impact […] The post Budget changes could cost each pharmacy ‘£12k more a year’ appeared first on The Pharmacist.

Independent Pharmacies 59

Independent Pharmacies Community Pharmacies 59

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

Express Pharma

NOVEMBER 4, 2024

Viraa Care, a health-tech platform focused on infant nutrition and pediatric feeding, has raised $108K in a pre-seed funding round. This funding milestone aims to enhance support for parents with research-driven guidance on infant care and childcare. The round included foreign direct investment (FDI) from a French investor, aligning with Viraa Care’s plans for international expansion and a commitment to influence global standards in child health.

59

59

Pharmafile

NOVEMBER 4, 2024

Samedan announces that their 2024 FlyPharma Conference, held in Office Park 4, Vienna AirportCity, Austria, has officially concluded! As a landmark event, FlyPharma Vienna 2024 has successfully wrapped, marking a pivotal gathering of industry professionals, expert speakers and delegates, from notable companies such as Sanofi, Takeda, Bayer, Amgen, Octapharma, Lufthansa, IATA, DHL, DoKaSch, Kühne + […] The post FlyPharma Vienna 2024: An Event to Remember!

59

59

Express Pharma

NOVEMBER 4, 2024

CPHI & PMEC India (26 th – 28 th November, 2024) – the largest pharma event in India – returns next month, with a record attendance of over 50,000 pharma executives expected from more than 150 countries. The news is a further boon for India – widely identified by analysts as a key beneficiary of recent macro tensions – as a strong CPHI & PMEC India is a leading indicator of growth for the country in the year ahead.

Biosimilars 59

Biosimilars 59

BioPharma Dive

NOVEMBER 4, 2024

Per terms, Novo could pay up to $285 million in upfront and milestone fees to Ascendis, which specializes in a kind of drug-enhancing technology.

67

67

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

pharmaphorum

NOVEMBER 4, 2024

Outlook Therapeutics' Lytenava is the first ophthalmic formulation of bevacizumab to be cleared for use by NICE for use in the NHS for wet AMD

64

64

BioPharma Dive

NOVEMBER 4, 2024

The news led to a stock surge on expectations that forthcoming data for the company’s experimental gene therapy for Rett syndrome may turn out positive.

62

62

pharmaphorum

NOVEMBER 4, 2024

Novo Nordisk puts $285m into a once-monthly GLP-1 agonist for obesity using technology developed by fellow Danish pharma Ascendis

69

69

Drug Channels

NOVEMBER 4, 2024

Here on Drug Channels , we have long highlighted the boom in provider-administered biosimilars. In contrast to the pharmacy market, adoption of these biosimilars is growing, prices are dropping, and formulary barriers continue to fall. Novel transparency information reveals that this good news doesn’t always translate into savings. Below, we rely on a unique data set from Turquoise Health to examine how much four national commercial health plans—Aetna, Anthem, Cigna, and UnitedHealthcare—paid ho

Biosimilars 53

Biosimilars Hospitals 53

Outsourcing Pharma

NOVEMBER 4, 2024

Thermo Fisher Scientific has joined forces with Labguru to integrate Labguruâs Electronic Lab Notebook (ELN) into Thermo Fisherâs Laboratory Information Management System (LIMS) and lab operations software.

53

53